Lyra Therapeutics Chairman Harlan Waksal receives $5M in 2022
Lyra Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 25, 2023
Lyra Therapeutics reported fiscal year 2022 executive compensation information on April 25, 2023.
In 2022, three executives at Lyra Therapeutics received on average a compensation package of $2.7M, a 171% increase compared to previous year.
Average pay of disclosed executives at Lyra Therapeutics
Harlan W. Waksal, Chairman, received $5M in total. 96% of Waksal's compensation, or $4.8M, was in option awards. Waksal also received $175K in salary and $12K in other compensation.
Maria Palasis, Chief Executive Officer, received a compensation package of $1.7M, which decreased by 1% compared to previous year. 50% of the compensation package, or $871K, was in option awards.
Richard Nieman, Chief Medical Officer, earned $1.4M in 2022.
Related executives
You may also like
Source: SEC filing on April 25, 2023.